MCL1 and cancer: Whilst detail of the specificity and direct pro-apoptotic impact of some of these drugs is currently unknown, preclinical evidence strongly indicates that MCL-1 can be effectively inhibited to confer an anti-cancer effect in vitro and in vivo.